Yale University's "Best of the Week" highlights a significant FDA approval for pediatric Type 1 diabetes treatment, crucial public health advice on heat safety, and historical insights into its role during the American Revolution.
The FDA recently cleared teplizumab for pediatric patients with Stage 3 Type 1 diabetes, a development described as "paradigm-shifting." Yale's Kevan Herold, who has dedicated over 30 years to studying Type 1 diabetes, served as the senior investigator on the clinical trial that demonstrated the drug's effectiveness in delaying disease progression.
In response to increasingly common extreme temperatures, Yale emergency medicine specialist David Della-Giustina provided a Q&A detailing the signs and symptoms of heat-related illnesses and prevention strategies for the summer. The university also reflected on its profound contributions during the American Revolution, noting how many of its leaders, students, and alumni actively supported the patriots' cause.
Further research from Yale biologist Martha Munoz challenged the concept of "evolutionary stasis" in woodland salamanders, uncovering significant physiological diversity that was previously unobserved. Munoz said, "the diversity was there all along. It just wasn't obvious from what meets the eye." Additionally, Yale marked America's 250th birthday by exploring its deep historical ties with the nation.